Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R McLeod

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Progress in Clinical Cancer|January 1, 1975
Factors influencing prognosis in malignant melanomaG R McLeod
British Journal of Clinical Practice. Supplement|March 1, 1988
Alpha-interferons in malignant melanomaG R McLeod
The Medical Journal of Australia|September 30, 1972
The surgery of primary melanoma: problems and practiceN C Davis, G R McLeod
The British Journal of Surgery|November 1, 1971
Elective lymph-node dissection for melanomaN C Davis, G R McLeod
Clinics in Dermatology|January 1, 1992
Historical overview of melanomaG R McLeod, N C Davis
British Journal of Haematology|October 1, 1991
Treatment of advanced malignant melanoma with recombinant interferon alfa-2a in combination with DTIC: long-term follow-up of two phase II studiesP Hersey, G R McLeod, D B Thomson
Cancer|September 26, 2000
Time trends of cutaneous melanoma in Queensland, Australia and Central EuropeC Garbe, G R McLeod, P G Buettner
The Journal of Investigative Dermatology|December 1, 1990
Clinical evaluation of interferons in malignant melanomaG R McLeod, D B Thomson, P Hersey
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Recombinant interferon alfa-2a in advanced malignant melanoma. A phase I-II study in combination with DTICG R McLeod, D B Thomson, P Hersey
Cancer|May 1, 1971
Genetic factor in malignant melanomaD C Wallace, L A Exton, G R McLeod
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Progress in Clinical Cancer|January 1, 1975
Factors influencing prognosis in malignant melanomaG R McLeod
British Journal of Clinical Practice. Supplement|March 1, 1988
Alpha-interferons in malignant melanomaG R McLeod
The Medical Journal of Australia|September 30, 1972
The surgery of primary melanoma: problems and practiceN C Davis, G R McLeod
The British Journal of Surgery|November 1, 1971
Elective lymph-node dissection for melanomaN C Davis, G R McLeod
Clinics in Dermatology|January 1, 1992
Historical overview of melanomaG R McLeod, N C Davis
British Journal of Haematology|October 1, 1991
Treatment of advanced malignant melanoma with recombinant interferon alfa-2a in combination with DTIC: long-term follow-up of two phase II studiesP Hersey, G R McLeod, D B Thomson
Cancer|September 26, 2000
Time trends of cutaneous melanoma in Queensland, Australia and Central EuropeC Garbe, G R McLeod, P G Buettner
The Journal of Investigative Dermatology|December 1, 1990
Clinical evaluation of interferons in malignant melanomaG R McLeod, D B Thomson, P Hersey
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Recombinant interferon alfa-2a in advanced malignant melanoma. A phase I-II study in combination with DTICG R McLeod, D B Thomson, P Hersey
Cancer|May 1, 1971
Genetic factor in malignant melanomaD C Wallace, L A Exton, G R McLeod
Pageof 3